Mereo Biopharma Group Plc盘中异动早盘股价大跌5.16%报2.98美元

自选股智能写手03-15

北京时间2024年03月15日22时55分，Mereo Biopharma Group Plc（MREO.us）股票出现异动，股价大幅下挫5.16%。截至发稿，该股报2.98美元/股，成交量61.9507万股，换手率0.44%，振幅4.14%。最近的财报数据显示，该股实现营业收入8.79百万美元，净利润-13.60百万美元，每股收益-0.11美元，毛利5.26百万美元，市盈率-9.48倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2419737903?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-15 22:55","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2419737903","market":"us","top_or_hot":-1,"title":"Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.16%报2.98美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年03月15日22时55分，Mereo Biopharma Group Plc（MREO.us）股票出现异动，股价大幅下挫5.16%。截至发稿，该股报2.98美元/股，成交量61.9507万股，换手率0.44%，振幅4.14%。最近的财报数据显示，该股实现营业收入8.79百万美元，净利润-13.60百万美元，每股收益-0.11美元，毛利5.26百万美元，市盈率-9.48倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152255527a4d17be&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.16%报2.98美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMereo Biopharma Group Plc盘中异动 早盘股价大跌5.16%报2.98美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-15 22:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152255527a4d17be&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月15日22时55分，Mereo Biopharma Group Plc（MREO.us）股票出现异动，股价大幅下挫5.16%。截至发稿，该股报2.98美元/股，成交量61.9507万股，换手率0.44%，振幅4.14%。最近的财报数据显示，该股实现营业收入8.79百万美元，净利润-13.60百万美元，每股收益-0.11美元，毛利5.26百万美元，市盈率-9.48倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152255527a4d17be&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152255527a4d17be&s=b","article_id":"2419737903","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152255527a4d17be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2419737903","pubTimestamp":1710514552,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年03月15日22时55分，Mereo Biopharma Group Plc股票出现异动，股价大幅下挫5.16%。截至发稿，该股报2.98美元/股，成交量61.9507万股，换手率0.44%，振幅4.14%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.25%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BK4505":"高瓴资本持仓","MREO":"Mereo Biopharma Group Plc"},"translate_title":"Mereo Biopharma Group Plc shares fell 5.16 percent to $2.98 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MREO":1},"content_text":"北京时间2024年03月15日22时55分，Mereo Biopharma Group Plc（MREO.us）股票出现异动，股价大幅下挫5.16%。截至发稿，该股报2.98美元/股，成交量61.9507万股，换手率0.44%，振幅4.14%。最近的财报数据显示，该股实现营业收入8.79百万美元，净利润-13.60百万美元，每股收益-0.11美元，毛利5.26百万美元，市盈率-9.48倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Better Therapeutics, Inc.、杰龙、Conduit Pharmaceuticals Inc C/Wts 22/09/2028(To Pur Com)涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为274.66%、77.45%、23.41%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)、联拓生物，振幅分别为94.29%、63.00%、49.00%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。该公司专注于旨在改善肿瘤学和罕见疾病预后治疗效果的疗法的开发和商业化。其肿瘤候选产品是etigilimab，用于实体瘤患者。正在开发的其他一些产品是setrusumab，alvelestat，leflutrozole，navicixizumab和acumapimod。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2419737903"}

Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.16%报2.98美元

精彩评论

Mereo Biopharma Group Plc盘中异动早盘股价大跌5.16%报2.98美元